16 November 2023

A global clinical trial for a new gonorrhoea treatment has shown promising results. The trial found that the oral antibiotic drug, zoliflodacin, is effective in treating gonorrhoea, a common bacterial sexually transmitted infection (STI) that spreads through unprotected vaginal, oral, or anal sex.

“This is an exciting result. It certainly places the spotlight on the much-needed field of STIs; and the need for new diagnostics, therapies and preventive interventions to reduce the burden of STIs in our community,” says Professor Sinead Delany-Moretlwe the director of research at the Reproductive Health and HIV Institute at the University of the Witwatersrand (Wits RHI).

Read the article